Targeting glutamate: the end of the monoamine hypothesis?


A number of recent papers have focused attention on the remarkable responses seen with glutamatergic agents in major depressive disorder (MDD), raising questions about theĀ  monoamine hypothesis of psychiatric disorders that has dominated biological psychiatry for a half century (Schildkraut JJ. Am J Psychiatry 1965;122:509-522).

It takes 30 seconds

Recommend to a Colleague Go back to home page